Inhibition of growth factor production and angiogenesis in human cancer cells by ZD1839 (Iressa), a selective epidermal growth factor receptor tyrosine kinase inhibitor. - Ciardello,F.; Caputo,R.; Bianca,R.; Damiano,V.; Fontanini,G.; Cuccato,S.; De Placido,S.; Bianco,A.R.; Tortora,P. (Clin Cancer Res, 2001)